278 related articles for article (PubMed ID: 19204488)
1. Methods used to calculate doses resulting from inhalation of Capstone depleted uranium aerosols.
Miller G; Cheng YS; Traub RJ; Little TT; Guilmette RA
Health Phys; 2009 Mar; 96(3):306-27. PubMed ID: 19204488
[TBL] [Abstract][Full Text] [Related]
2. Physicochemical characterization of Capstone depleted uranium aerosols I: uranium concentration in aerosols as a function of time and particle size.
Parkhurst MA; Cheng YS; Kenoyer JL; Traub RJ
Health Phys; 2009 Mar; 96(3):251-65. PubMed ID: 19204484
[TBL] [Abstract][Full Text] [Related]
3. Aerosol sampling system for collection of Capstone depleted uranium particles in a high-energy environment.
Holmes TD; Guilmette RA; Cheng YS; Parkhurst MA; Hoover MD
Health Phys; 2009 Mar; 96(3):221-37. PubMed ID: 19204482
[TBL] [Abstract][Full Text] [Related]
4. Physicochemical characterization of Capstone depleted uranium aerosols II: particle size distributions as a function of time.
Cheng YS; Kenoyer JL; Guilmette RA; Parkhurst MA
Health Phys; 2009 Mar; 96(3):266-75. PubMed ID: 19204485
[TBL] [Abstract][Full Text] [Related]
5. Physicochemical characterization of Capstone depleted uranium aerosols III: morphologic and chemical oxide analyses.
Krupka KM; Parkhurst MA; Gold K; Arey BW; Jenson ED; Guilmette RA
Health Phys; 2009 Mar; 96(3):276-91. PubMed ID: 19204486
[TBL] [Abstract][Full Text] [Related]
6. Physicochemical characterization of Capstone depleted uranium aerosols IV: in vitro solubility analysis.
Guilmette RA; Cheng YS
Health Phys; 2009 Mar; 96(3):292-305. PubMed ID: 19204487
[TBL] [Abstract][Full Text] [Related]
7. Capstone depleted uranium aerosol biokinetics, concentrations, and doses.
Guilmette RA; Miller G; Parkhurst MA
Health Phys; 2009 Mar; 96(3):328-42. PubMed ID: 19204489
[TBL] [Abstract][Full Text] [Related]
8. Calculating Capstone depleted uranium aerosol concentrations from beta activity measurements.
Szrom F; Falo GA; Parkhurst MA; Whicker JJ; Alberth DP
Health Phys; 2009 Mar; 96(3):238-50. PubMed ID: 19204483
[TBL] [Abstract][Full Text] [Related]
9. Overview of the Capstone depleted uranium study of aerosols from impact with armored vehicles: test setup and aerosol generation, characterization, and application in assessing dose and risk.
Parkhurst MA; Guilmette RA
Health Phys; 2009 Mar; 96(3):207-20. PubMed ID: 19204481
[TBL] [Abstract][Full Text] [Related]
10. Radiological risk assessment of Capstone depleted uranium aerosols.
Hahn FF; Roszell LE; Daxon EG; Guilmette RA; Parkhurst MA
Health Phys; 2009 Mar; 96(3):352-62. PubMed ID: 19204491
[TBL] [Abstract][Full Text] [Related]
11. Inhalation and ingestion intakes with associated dose estimates for level II and level III personnel using Capstone study data.
Szrom F; Falo GA; Lodde GM; Parkhurst MA; Daxon EG
Health Phys; 2009 Mar; 96(3):363-79. PubMed ID: 19204492
[TBL] [Abstract][Full Text] [Related]
12. Applications of Capstone depleted uranium aerosol risk data to military combat risk management.
Daxon EG; Parkhurst MA; Melanson MA; Roszell LE
Health Phys; 2009 Mar; 96(3):380-92. PubMed ID: 19204493
[TBL] [Abstract][Full Text] [Related]
13. Conclusions of the Capstone depleted uranium aerosol characterization and risk assessment study.
Parkhurst MA; Guilmette RA
Health Phys; 2009 Mar; 96(3):393-409. PubMed ID: 19204494
[TBL] [Abstract][Full Text] [Related]
14. Dose assessment for inhalation intakes in complex, energetic environments: experience from the US Capstone study.
Guilmette RA; Parkhurst MA
Radiat Prot Dosimetry; 2007; 127(1-4):516-20. PubMed ID: 17766261
[TBL] [Abstract][Full Text] [Related]
15. Assessing the renal toxicity of Capstone depleted uranium oxides and other uranium compounds.
Roszell LE; Hahn FF; Lee RB; Parkhurst MA
Health Phys; 2009 Mar; 96(3):343-51. PubMed ID: 19204490
[TBL] [Abstract][Full Text] [Related]
16. Measuring aerosols generated inside armoured vehicles perforated by depleted uranium ammunition.
Parkhurst MA
Radiat Prot Dosimetry; 2003; 105(1-4):167-70. PubMed ID: 14526950
[TBL] [Abstract][Full Text] [Related]
17. Determination of the solubility and size distribution of radioactive aerosols in the uranium processing plant at NRCN.
Kravchik T; Oved S; Paztal-Levy O; Pelled O; Gonen R; German U; Tshuva A
Radiat Prot Dosimetry; 2008; 131(4):418-24. PubMed ID: 18676447
[TBL] [Abstract][Full Text] [Related]
18. Effective dose scaling factors for use with uranium series cascade impactor data: a reassessment using the IMBA code.
Kim KP; Wu CY; Birky BK; Bolch WE
Health Phys; 2006 Oct; 91(4):331-7. PubMed ID: 16966876
[TBL] [Abstract][Full Text] [Related]
19. Characterisation and dissolution of depleted uranium aerosols produced during impacts of kinetic energy penetrators against a tank.
Chazel V; Gerasimo P; Dabouis V; Laroche P; Paquet F
Radiat Prot Dosimetry; 2003; 105(1-4):163-6. PubMed ID: 14526949
[TBL] [Abstract][Full Text] [Related]
20. Use of air monitoring and experimental aerosol data for intake assessment for Mayak plutonium workers.
Zaytseva YV; Tretyakov FD; Romanov SA; Miller G; Bertelli L; Guilmette RA
Radiat Prot Dosimetry; 2007; 127(1-4):535-9. PubMed ID: 17848389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
